Evidence map›Paper›PMID 42512096›Full record

ArticleBiomedicines2026

A Self-Assembling Peptide Platform for Intratumoral Doxorubicin Delivery and Preliminary Immune-Related Modulation in B16-F10 Melanoma.

Xufang Ying, Jingjing Peng, Zhiqing Ben, Xiaoyan Bao, Linjie Wu, Xin Tan, Xiaoyan Sun, Yufan Yang, Yiqing Shen, Zhicheng Zhang and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xufang YingInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.ORCID 0009-0001-9375-0729
Jingjing PengInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Zhiqing BenInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Xiaoyan BaoInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Linjie WuInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Xin TanInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Xiaoyan SunInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Yufan YangInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Yiqing ShenInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Zhicheng ZhangThe Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310058, China.
Ruolin JiangInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Yaxin QinInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Lin ZhouInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.
Min HanInstitute of Pharmaceutics, School of Pharmacy, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0001-9373-8466
Shugang YangDepartment of Gastrointestinal Surgery 2 Section, Institute of Abdominal Surgery, The First Affiliated Hospital, Fujian Medical University, 20th, Chazhong Road, Fuzhou 350005, China.

Funding

Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China No. LHDMZ24H300002Jinhua City Science and Technology Project No.2024-3-145Jinhua Science and Technology Plan Projects No. 2026-1-029National Natural Science Foundation of China No.82373206
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD3-recognition peptidechemo-immunomodulationdoxorubicinlocal drug deliverymelanomaself-assembling peptide

Identifiers

PMID42512096
PMCPMC13406409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.